MiR-206, miR-148a, miR-125a-5p and miR-129 can target BCL2, reducing its anti-apoptotic role and the overexpression of these miRNAs increased the sensitivity of CRC cells to 5-FU [49–52]. The gene discussed is BCL2; the disease is colorectal carcinoma.